Your browser doesn't support javascript.
loading
Ustekinumab is effective in biological refractory Crohn's disease patients-regardless of approval study selection criteria.
Saman, Sadik; Goetz, Martin; Wendler, Judith; Malek, Nisar P; Wehkamp, Jan; Klag, Thomas.
Afiliação
  • Saman S; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Goetz M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Wendler J; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Malek NP; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Wehkamp J; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Klag T; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
Intest Res ; 17(3): 340-348, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31129948

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article